Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 4
2010 7
2011 3
2012 4
2013 5
2014 2
2015 1
2016 11
2017 2
2018 3
2019 3
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth.
Weissenbacher T, Laubender RP, Witkin SS, Gingelmaier A, Schiessl B, Kainer F, Friese K, Jeschke U, Dian D, Karl K. Weissenbacher T, et al. Arch Gynecol Obstet. 2013 Apr;287(4):673-85. doi: 10.1007/s00404-012-2629-3. Epub 2012 Nov 29. Arch Gynecol Obstet. 2013. PMID: 23192623
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status.
Vilsmaier T, Heidegger HH, Schröder L, Trapp E, Zehni AZ, Rack B, Janni W, Mahner S, Weissenbacher T, Jeschke U, Mumm JN; SUCCESS Study Group. Vilsmaier T, et al. Among authors: weissenbacher t. Arch Gynecol Obstet. 2021 Jan;303(1):217-230. doi: 10.1007/s00404-020-05793-y. Epub 2020 Sep 14. Arch Gynecol Obstet. 2021. PMID: 32929618 Free PMC article.
Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells-Results From the SUCCESS A Trial.
Hepp P, Fasching PA, Beckmann MW, Fehm T, Salmen J, Hagenbeck C, Jäger B, Widschwendter P, de Gregorio N, Schochter F, Mahner S, Harbeck N, Weissenbacher T, Kurt AG, Friedl TWP, Janni W, Rack B. Hepp P, et al. Among authors: weissenbacher t. Clin Breast Cancer. 2018 Oct;18(5):e1103-e1110. doi: 10.1016/j.clbc.2018.06.006. Epub 2018 Jun 18. Clin Breast Cancer. 2018. PMID: 30017795
Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.
Mutschler NS, Scholz C, Friedl TWP, Zwingers T, Fasching PA, Beckmann MW, Fehm T, Mohrmann S, Salmen J, Ziegler C, Jäger B, Widschwendter P, de Gregorio N, Schochter F, Mahner S, Harbeck N, Weissenbacher T, Jückstock J, Janni W, Rack B. Mutschler NS, et al. Among authors: weissenbacher t. Clin Breast Cancer. 2018 Apr;18(2):175-183. doi: 10.1016/j.clbc.2018.01.008. Epub 2018 Jan 31. Clin Breast Cancer. 2018. PMID: 29598955 Clinical Trial.
CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Rack B, Jückstock J, Trapp E, Weissenbacher T, Alunni-Fabbroni M, Schramm A, Widschwendter P, Lato K, Zwingers T, Lorenz R, Tesch H, Schneeweiss A, Fasching P, Mahner S, Beckmann MW, Lichtenegger W, Janni W; SUCCESS Study Group. Rack B, et al. Among authors: weissenbacher t. Tumour Biol. 2016 Oct;37(10):13769-13775. doi: 10.1007/s13277-016-5171-2. Epub 2016 Aug 1. Tumour Biol. 2016. PMID: 27481512 Clinical Trial.
The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.
Widschwendter P, Friedl TW, Schwentner L, DeGregorio N, Jaeger B, Schramm A, Bekes I, Deniz M, Lato K, Weissenbacher T, Kost B, Andergassen U, Jueckstock J, Neugebauer J, Trapp E, Fasching PA, Beckmann MW, Schneeweiss A, Schrader I, Rack B, Janni W, Scholz C. Widschwendter P, et al. Among authors: weissenbacher t. Breast Cancer Res. 2015 Sep 18;17(1):129. doi: 10.1186/s13058-015-0639-3. Breast Cancer Res. 2015. PMID: 26385214 Free PMC article. Clinical Trial.
43 results